Navigation Links
Uses and Applications of FuGENE 6 Transfection Reagent

Protocol Instructions for Users Who are New to Transfection

Below, a standard protocol for the DNA transfection of cultured cells using FuGENE 6 is presented that has been specially designed for scientists who are new to transfection.

1. Prepare cells the day before transfection
  • Ensure the cells are growing well and are in log phase. Occasionally cells slow down when they reach confluence, and it can take a day or two to recover.
  • For monolayers, plate the cells so they will only be 50-80% confluent the following day.

  • Plate the cells in medium that does not contain antibiotics. Transfection is lower in some cell lines when they are grown in antibiotics. Possible explanations are that the transfection reagent may bring the antibiotic into the cell and decrease transfection, or the complex may interact with the antibiotic, resulting in less transfection.
  • For most adherent cell lines, plate 100,000-300,000 cells in 2 ml medium (50,000 to 150,000 cells/ml) in one well of a 6-well plate. Plan to test at least 3 ratios of reagent to DNA.. See the table below for a suggested layout of a 6-well plate.
(A) Cell Control

    No reagent

    No DNA
(B) Reagent Control

    6 l reagent

    No DNA
(C) DNA-Control

    No reagent

    1 g DNA
(D) 3:1 ratio

    3 l reagent

    1 g DNA
(E) 3:2 ratio

    3 l reagent

    2 g DNA
(F) 6:1 ratio

    6 l reagent

    1 g DNA

2. Prepare the complex example given for 6-well plate

Prepare the DNA



  • Select a plasmid that you know transfects your cell line, and make sure you are able to measure the expression of reporter gene or transfected protein. Plasmids with reporter genes are available from Roche Applied Science.
  • Handle the DNA as aseptically as possible to avoid contaminating your cell cultures during the transfection. Use sterile pipettes, tips, vials, etc.
  • Accurate DNA concentrations are important. Determine the concentration of the DNA with a spectrophotometer. Transfection-grade DNA should have a 260/280 ratio of 1.8.
  • Check the stock DNA concentration, and determine how much you will need for 1 and 2 g. If the stock is 2 g/l, then decide if you can accurately pipet 0.5 l. It might be better to dilute the DNA using procedures that give accurate dilutions. If you need to dilute the DNA, use sterile DNase-free water or sterile DNase-free TE buffer as the diluent.
  • Calculate accordingly for your DNA concentrations (i.e., concentrations of 0.5 g/l work well; for 1 g, measure 2 l, and for 2 g, measure 4 l).
Prepare the FuGENE 6 Transfection Reagent

  • Remove the FuGENE 6 Reagent from the refrigerator or freezer and allow it to warm to room temperature. Meanwhile, look at the cells microscopically. Make sure they look healthy and are 50-80% confluent. Return the cells to the incubator.
  • Warm serum-free DMEM (no additives) to room temperature. Aliquot 94-100 l into each of 6 tubes as indicated below. Use sterile Eppendorf tubes or small sterile polystyrene tubes labeled:
    • A (100 l)
    • B (94 l)
    • C (100 l)
    • D (97 l)
    • E (97 l)
    • F (94 l), corresponding to the plate layout above.
  • Mix the room-temperature FuGENE 6 Reagent by tapping or briefly vortexing (1 second).
    Carefully add the FuGENE 6 Reagent to the serum-free medium as follows.
    • 6 l to Tube B
    • 3 l to Tube D (3:1 ratio)
    • 3 l to Tube E (3:2 ratio)
    • 6 l to Tube F (6:1 ratio)
  • Ensure the entire amount of reagent is delivered directly from the pipette tip into the serum-free medium. Avoid contact of the FuGENE 6 Transfection Reagent with the walls of the tube containing the serum-free medium. Avoid a FuGENE 6 Reagent layer on top of the serum-free medium. Once the FuGENE 6 Reagent is added, immediately tap, flick, or vortex for 1 second to ensure adequate mixing of the components.
  • Incubate at room temperature for 5 minutes.

Make the complex

Add the DNA to each tube (see table below). The amount added will depend on the starting concentration of DNA.

Tube DNA at 0.5 g/l DNA at 1 g/l DNA at 2 g/l
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Uses and Applications FuGENE Transfection Reagent

(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that ... Cancer Care , a national support services organization for people ... educational programs for people facing lung and ovarian cancers.  The ... their families become aware of options available to help treat ...
... graphite particles 1000 times smaller than the width of a ... boost the efficiencyand profitabilityof solar power plants. Photovoltaic (PV) ... but they,re not necessarily the best solar power solution. "The ... only a fraction of the sunlight that hits them, and ...
... PARIS, April 5, 2011 Cellectis (Alternext: ALCLS), the genome ... signed an agreement with the Caisse des Depots (a French ... in two steps, reserved in equal parts to Cellectis and ... later than January 31, 2012, and is subject to the ...
Cached Biology Technology:Morphotek®, Inc. Receives Beacon Award From CancerCare 2Morphotek®, Inc. Receives Beacon Award From CancerCare 3Nanoparticles improve solar collection efficiency 2Cellectis and Caisse des Depots Sign Agreement on a Project for the Industrial Development of iPS Cells 2Cellectis and Caisse des Depots Sign Agreement on a Project for the Industrial Development of iPS Cells 3
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014 /PRNewswire-USNewswire/ ... a Good Clinical Practices (GCP) audit to confirm ... Administration (FDA) regulations. This accomplishment enables HITLAB to ... trials utilizing the highest principles for patient safety ... to improve global healthcare access, quality, and delivery ...
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ... 2015-2019"  report to their offering. ... advances in technology. With continuous advances in technology, ... the latest standard that meets the needs and ...
(Date:12/10/2014)...  Valencell, a leader in performance biometric data sensor ... from its licensees for highly accurate, clinically validated biometric ... coming from fitness and health sectors, but first responders/military ... is only as useful as the biometric data it ... in long-term mass consumer adoption of wearable products," said ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... GAINESVILLE, Fla. New University of Florida research puts to ... the last glacial period. It turns out it ended up ... The findings have implications for modern-day global warming, said ... of the paper, which is published in this week,s journal ...
... team of researchers based at the Institute of Vertebrate ... professor at Washington University in St. Louis, has discovered ... anthropologists perceptions of the emergence of modern humans in ... published Oct. 25 in the online early edition of ...
... HOUSTON, Oct. 25, 2010 Some unexpected effects ... and reverse blindness have been uncovered by a University ... Donald A. Fox, a professor of vision sciences ... findings in a paper titled "Low-Level Gestational Lead Exposure ...
Cached Biology News:UF research gives clues about carbon dioxide patterns at end of Ice Age 2UF research gives clues about carbon dioxide patterns at end of Ice Age 3Unexpected findings of lead exposure may lead to treating blindness 2Unexpected findings of lead exposure may lead to treating blindness 3
... T2-04 is an ultra-compact pump available in single ... and ideal for use in portable air and ... this pump works well in environments where DC ... compact size are critical., Offers ultra-compact size, ...
Curcumin is an extract of turmeric root with antioxidant, anti-tumor promoter, and anti-inflammatory properties. Curcumin inhibits the induction of NOS in macrophages....
Total Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... Lone Wolf valve has the highest performance ... available on the market. This VSO valve ... and ensures maximum accuracy., Achieves rapid, ... and patient comfort. , Maintains ideal flow ...
Biology Products: